ArticleNature microbiology2019
Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Erratum issuedAbstract read
In one paragraph
Article in Nature microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 142 papers.
0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
142 citing papers in PubMed, 234 citations in OpenAlex.
- Clinicopathological features and therapeutic advances in primary pulmonary lymphoepithelioma-like carcinoma (Review).Oncology letters · 2026Review
- Epstein-Barr virus receptors: classification, functional mechanisms, and pathogenic implications.Journal of virology · 2026Review
- Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult Patient.Internal medicine (Tokyo, Japan) · 2026Article
- CD80 (B7-1) as a potential therapeutic target in Epstein-Barr virus‑associated B cell diseases.Scientific reports · 2026Article
- Immunotherapy in NK/T-Cell Lymphoma: Mechanisms, Clinical Evidence, Resistance, and Emerging Multimodal Strategies.Cancers · 2026Review
- Viral-driven oncogenesis in T/NK-cell lymphomas: parallels and divergences between HTLV-1 and EBV.International journal of hematology · 2026Review
- EBV Genome Variations and Association With Diseases.Journal of medical virology · 2026Review
- SFK Inhibition Suppresses EBV-Encoded BART miRNAs and Induces Apoptosis in EBV-Positive Gastric Epithelial Cells.Cancers · 2026Article
- EBV-Driven NK/T-Cell Lymphoproliferative Disorders: Clinical Diversity and Molecular Insights.Lymphatics · 2026Article
- Avoidance of related donors in CAEBV with germline immune variants: long-termoutcome of matched unrelated donor HSCT - a case report.Annals of hematology · 2026Article
- The role of Epstein-Barr virus in NK/T cell lymphoproliferative disorders: molecular mechanisms and potential therapeutic strategies.Frontiers in immunology · 2026Review
- Frequent Novel Viral Focal Copy Number Gains Potentiate Radiosensitivity in Natural Killer/T-Cell Lymphoma.Cancer communications (London, England) · 2026Article
- Case Report: A case of severe mosquito bite allergy in an elderly patient.Frontiers in immunology · 2026Article
- Molecular pathogenesis and evolving treatment landscape of extranodal NK/T-cell lymphoma.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2026Review
- Epstein-Barr Virus-Associated T/NK-Cell Neoplasms.Journal of medical virology · 2026Review
- Dissecting Epstein-Barr Virus Dependence Across Diverse Infected Cell Models.bioRxiv : the preprint server for biology · 2025Article
- Lysine-specific histone demethylase complex restricts Epstein-Barr virus lytic reactivation.Nature microbiology · 2025Article
- Expression profiling of Epstein-Barr virus-derived microRNA in systemic chronic active EBV disease.International journal of hematology · 2025Article
- The critical role of ferroptosis in virus-associated hematologic malignancies and its potential value in antiviral-antitumor therapy.Virulence · 2025Review
- Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas.Annals of medicine · 2025Article
82 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
38 authors at 14 institutions in 1 country.
Yusuke OkunoCenter for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
Takayuki MurataDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yoshitaka SatoDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0002-8541-6413
Hideki MuramatsuDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yoshinori ItoDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takahiro WatanabeDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Tatsuya OkunoDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Norihiro MurakamiDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kenichi YoshidaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Akihisa SawadaDepartment of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
Masami InoueDepartment of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
Keisei KawaDepartment of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
Masao SetoDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Koichi OhshimaDepartment of Pathology, Kurume University School of Medicine, Kurume, Japan.
Yuichi ShiraishiLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kenichi ChibaLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Hiroko TanakaLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Satoru MiyanoLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Yohei NaritaDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0002-8867-3669
Masahiro YoshidaDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Fumi GoshimaDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Jun-Ichi KawadaDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0003-1553-2539
Tetsuya NishidaDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hitoshi KiyoiDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Seiichi KatoDepartment of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Shigeo NakamuraDepartment of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Satoko MorishimaDivision of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.ORCID http://orcid.org/0000-0002-7391-4271
Tetsushi YoshikawaDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.
Shigeyoshi FujiwaraDepartment of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
Norio ShimizuCenter for Stem Cell and Regenerative Medicine, Division of Advanced Biomedical Engineering Research, Institute of Research, Tokyo Medical and Dental University, Tokyo, Japan.
Yasushi IsobeDivision of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Masaaki NoguchiDepartment of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan.
Atsushi KikutaDepartment of Pediatric Oncology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Keiji IwatsukiDepartment of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Yoshiyuki TakahashiDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Seiji KojimaDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Seishi OgawaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hiroshi KimuraDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan. hkimura@med.nagoya-u.ac.jp.ORCID http://orcid.org/0000-0001-8063-5660
Nagoya University · JPThe University of Tokyo · JPNagoya University Hospital · JPOsaka Women's and Children's Hospital · JPKurume University · JPKyoto University · JPFujita Health University · JPFukushima Medical University · JPJuntendo University Urayasu Hospital · JPNational Center For Child Health and Development · JPOkayama University · JPSt. Marianna University School of Medicine · JPTokyo Medical and Dental University · JPUniversity of the Ryukyus · JP
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epstein-Barr virus (EBV) infection is highly prevalent in humans and is implicated in various diseases, including cancer
Indexed as
Gene DeletionAnimalsDNA-Binding ProteinsDNA-Directed DNA PolymeraseEpstein-Barr Virus InfectionsFemaleHematologic NeoplasmsHerpesvirus 4, HumanHeterograftsHumansImmediate-Early ProteinsLymphoproliferative DisordersMaleMiceMicroRNAsMiddle AgedBALF5 protein, Epstein-barr virusBRLF1 protein, Human herpesvirus 4BZLF1 protein, Herpesvirus 4, HumanDNA-Binding ProteinsDNA-Directed DNA PolymeraseImmediate-Early ProteinsMicroRNAsTrans-ActivatorsViral Proteins
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.